Who are ICON Public Limited Company's main suppliers?

ICON Public Limited Company (ICLR) key suppliers include: Johnson & Johnson. View the full supplier network at chainsifter.com/chain/ICLR.

Who are ICON Public Limited Company's major customers?

ICON Public Limited Company (ICLR) key customers include: LARGE-GLOBAL-PHARMACEUTICAL-COMPANY, Thermo Fisher Scientific Inc., Thermo Fisher Scientific Inc., COMPANY-COUNTRY-GROUP, ICON-CLINICAL-RESEARCH-AUSTRIA-GMBH and 5 more. View the full customer network at chainsifter.com/chain/ICLR.

What sector is ICON Public Limited Company in?

ICON Public Limited Company (ICLR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ICON Public Limited Company (ICLR): 12 Verified Supply Chain Relationships

1Suppliers

10Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

ICON Public Limited Company (ICLR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

13Total relationships

1Distinct source URLs

5High confidence

0.720Average confidence

2026-10-29Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

ICON Public Limited Company Suppliers

Ticker	Name	Confidence	Evidence
JNJ	Johnson & Johnson	62%	Reciprocal relationship from JNJ graph: Reciprocal relationship from ICLR graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ICLR graph: Reciprocal relationship from JNJ grap…

ICON Public Limited Company Customers

Ticker	Name	Confidence	Evidence
LARGE-GLOBAL-PHARMACEUTICAL-COMPANY	LARGE-GLOBAL-PHARMACEUTICAL-COMPANY	90%	Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 7.7% of revenue for the year.
TMO	Thermo Fisher Scientific Inc.	85%	Reciprocal relationship from TMO graph: Reciprocal relationship from ICLR graph: responsibility for the maintenance of key client relationships. Our aim is to develop deeper relationships within our …
TMO	Thermo Fisher Scientific Inc.	85%	responsibility for the maintenance of key client relationships. Our aim is to develop deeper relationships within our client base to gain repeat business and enable us new opportunities to penetrate …
COMPANY-COUNTRY-GROUP	COMPANY-COUNTRY-GROUP	62%	guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines,…
ICON-CLINICAL-RESEARCH-AUSTRIA-GMBH	ICON-CLINICAL-RESEARCH-AUSTRIA-GMBH	62%	guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines,…
ICON-CLINICAL-RESEARCH-PTY-LIMITED	ICON-CLINICAL-RESEARCH-PTY-LIMITED	62%	guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines,…
ICON-INVESTMENTS-SIX-DESIGNATED-ACTIVITY-COMPANY	ICON-INVESTMENTS-SIX-DESIGNATED-ACTIVITY-COMPANY	62%	ting to $ 500.0 million and $ 202.0 million respectively as of the date of acquisition, becoming fully amortized on July 1, 2024. On August 19, 2024, the Company acquired KCR. The acquisition resulte…
KCR-CRO-PTY-LTD	KCR-CRO-PTY-LTD	62%	guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines,…
PHARMACEUTICAL-RESEARCH-ASSOCIATES-PTY-LIMITED	PHARMACEUTICAL-RESEARCH-ASSOCIATES-PTY-LIMITED	62%	guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines,…
RPS-RESEARCH-AUSTRIA-GMBH	RPS-RESEARCH-AUSTRIA-GMBH	62%	guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines,…

ICON Public Limited Company Debt Obligations

Instrument	Description	Confidence	Evidence
ICLR-DEBT	Debt stack $2.2B	90%	Market cache reports total debt of $2.2B.

ICON Public Limited Company Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ICON Public Limited Company.

ICON Public Limited Company Ownership

Holder	Name	Confidence	Evidence
ICLR-OWNER-ARTISAN-PARTNERS-LIMITED-PARTNER	Artisan Partners Limited Partnership	90%	13F overlay lists Artisan Partners Limited Partnership as top holder; 426 tracked holders.

ICON Public Limited Company Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
TWST	Twist Bioscience Corporation	100.00	2
BHPLF	BHP Group Limited	100.00	2
SOLV	Solventum Corporation	100.00	2
JNJ	Johnson & Johnson	100.00	1	['supplier']
BHP	BHP Group Limited	100.00	2
CLLS	Cellectis S.A.	100.00	2
IDXG	Interpace Biosciences, Inc.	100.00	2
AZTA	Azenta, Inc.	100.00	2
TMO	Thermo Fisher Scientific Inc.	100.00	1	['customer']
IONS	Ionis Pharmaceuticals, Inc.	100.00	2
BTAI	BioXcel Therapeutics, Inc.	100.00	2
MXCT	MaxCyte, Inc.	100.00	2
IMTX	Immatics N.V.	100.00	2
GH	Guardant Health, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	50.00	2
CBIH	Cannabis Bioscience International Holdings, Inc.	50.00	2
AORT	Artivion, Inc.	50.00	2
DNABW	Ginkgo Bioworks Holdings, Inc.	50.00	2
FCX	Freeport-McMoRan Inc.	50.00	2
CLWT	Euro Tech Holdings Company Limited	50.00	2

ICON Public Limited Company Supply Chain